Wound healing is a finely tuned biological process, but it is also remarkably fragile. When this complex sequence of events is interrupted or fails, it can lead to the formation of chronic wounds—injuries that do not progress through the normal stages of healing in a predictable and timely manner. These persistent wounds pose significant physical and emotional challenges for patients and place a substantial burden on healthcare systems. Unlike acute
wounds, which follow an expected timeline of hemostasis, inflammation, proliferation, and remodeling, chronic wounds often remain stuck in a prolonged inflammatory phase, preventing proper tissue repair and impeding recovery. Understanding the myriad factors that contribute to their development is crucial for effective management and treatment.
Defining and Identifying Chronic Wounds
A wound is generally classified as chronic if it has not healed within three months. This prolonged non-healing state can arise from various underlying issues that disrupt any of the normal stages of wound healing, though disruption of the inflammatory phase is particularly common. Factors such as infection or bacterial burden, ischemia (insufficient blood supply), the presence of necrotic tissue, improper moisture balance at the wound site, or underlying systemic diseases like diabetes mellitus can all contribute to a wound becoming chronic. These wounds can affect only the epidermis and dermis, or they can extend deeper, impacting tissues all the way to the fascia. While they may originate from the same causes as acute wounds, such as trauma or surgery, their chronicity stems from the body's inability to overcome factors like repeated trauma, continuous pressure, ischemia, or illness.
Patients with chronic wounds frequently report persistent pain, often describing it as dominant in their lives, occurring at night, at rest, and with activity. This pain is a critical aspect of chronic wound management that healthcare providers must prioritize. Additionally, the skin surrounding the wound, known as periwound skin, can suffer damage from excessive exudate and other bodily fluids, leading to issues like maceration, excoriation, dry fragile skin, hyperkeratosis, callus formation, and eczema. These problems interfere with the integrity of the periwound skin, potentially creating entry points for infection and hindering wound closure by causing wound edge deterioration.
Contributing Factors and Pathogenesis
Several comorbid factors significantly contribute to the formation and persistence of chronic wounds. Ischemia, often repetitive, is a major player, causing tissue inflammation and attracting neutrophils, which release factors like interleukins, chemokines, leukotrienes, and complement factors. Old age is another significant factor; the skin of older individuals is more susceptible to damage, and their cells may not proliferate as quickly or respond adequately to stress. Genetic skin disorders, such as epidermolysis bullosa, also predispose individuals to chronic, non-healing wounds due to skin fragility. Systemic illnesses like vasculitis, immune suppression (whether from illness or long-term medication like steroids), and diseases causing ischemia further complicate healing. Emotional stress can also negatively impact healing by potentially raising blood pressure and cortisol levels, which can lower immunity.
Repeated physical trauma can perpetuate chronic wound formation by continuously triggering the inflammatory cascade. This can be accidental, like a leg repeatedly bumping against a wheelchair, or intentional, as seen in "skin popping" among heroin users, which severely damages tissue and often leads to chronic ulcers. In some tragic cases, a child's non-healing wound might indicate Munchausen syndrome by proxy, where an abuser intentionally inflicts harm. Furthermore, what appears to be a chronic wound could sometimes be a malignancy, as cancerous tissue can grow until blood supply is cut off, leading to ulceration. Conversely, chronic wounds, particularly those with repetitive tissue damage, can stimulate rapid cell proliferation and potentially lead to cancers like squamous cell carcinoma.
Key Types of Chronic Wounds and Treatment Strategies
The vast majority of chronic wounds fall into three main categories: venous ulcers, diabetic ulcers, and pressure ulcers. Venous ulcers, predominantly affecting the elderly and accounting for 70-90% of chronic wounds, typically occur in the legs due to venous hypertension caused by dysfunctional vein valves. Diabetic ulcers are a growing concern, as diabetes causes neuropathy, impairing pain perception and leading to unnoticed injuries, as well as immune compromise and damage to small blood vessels, hindering tissue oxygenation. Pressure ulcers, common in individuals with limited mobility, result from ischemia when pressure on tissue exceeds capillary pressure, restricting blood flow and causing damage, especially to muscle tissue.
At a cellular level, chronic wounds exhibit excessive levels of inflammatory cytokines and proteases, which degrade the extracellular matrix (ECM) and collagen, disrupting tissue repair. Neutrophils, while fighting pathogens, release inflammatory cytokines and enzymes that damage cells, DNA, lipids, proteins, and the ECM. They also produce Reactive Oxygen Species (ROS) to kill bacteria, but in chronic wounds, neutrophils persist longer, leading to higher levels of inflammatory cytokines and ROS. This excess of proteases and ROS in chronic wound fluid can inhibit cell growth and break down growth factors, creating an uncoordinated healing response. Inadequate growth factor levels, a failure of fibroblasts to produce sufficient ECM proteins, and issues with keratinocyte epithelialization also contribute to chronicity.
Treatment for chronic wounds aims to address these underlying problems, including ischemia, bacterial load, and protease imbalance. Approaches include antibiotics, debridement (removal of dead tissue), irrigation, negative-pressure wound therapy (NPWT), warming, oxygenation, and maintaining a moist wound environment. Debridement is particularly critical, as devitalized tissue serves as a nutrient source for bacteria and creates a physical barrier to healing. NPWT, also known as vacuum-assisted closure, improves ischemic tissues, removes wound fluid, reduces swelling, and promotes granulation tissue formation. Novel approaches, such as self-adaptive wound dressings, use smart polymers to regulate moisture, remove slough and necrotic tissue, and reduce bacterial load. Managing chronic pain associated with these wounds is also paramount, often requiring a holistic assessment and a combination of local and systemic treatments. The goal is always to create an environment that allows the wound to heal as quickly as possible, restoring both form and function.
